ScholarLink (思领科)
错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetic susceptibility to breast cancer increases the risk of neutropenia and agranulocytosis: insights from Mendelian randomization

  • 期刊论文

  • 发表日期：

    2024年6月29日

查看全文
  • Changlong Wei,
  • Gongyin Zhang,
  • Changwang Li,
  • Jinsheng Zeng

摘要

Purpose

The causal relationship between breast cancer and its estrogen receptor (ER) subtypes and neutropenia and agranulocytosis is unclear.

Methods

In two-sample Mendelian randomization (MR), we used inverse variance weighting (IVW), Bayesian weighted MR (BWMR), MR-Egger, weighted median, simple mode, and weighted mode methods to analyze causality for ER-positive breast cancer, ER-negative breast cancer, overall breast cancer, and drug-induced neutropenia and agranulocytosis. To validate the results, we performed the analysis again using GWAS data on neutropenia from different databases. In multivariable MR (MVMR), we assessed the independent effects of ER-positive and ER-negative breast cancer on causality.

Results

Two-sample MR analysis showed a causal relationship between ER-positive breast cancer (IVW odds ratio (OR) = 1.319, P = 7.580 × 10−10), ER-negative breast cancer (OR = 1.285, P = 1.263 × 10−4), overall breast cancer (OR = 1.418, P = 2.123 × 10−13), and drug-induced neutropenia and a causal relationship between ER-positive breast cancer (OR = 1.349, P = 1.402 × 10−7), ER-negative breast cancer (OR = 1.235, P = 7.615 × 10−3), overall breast cancer (OR = 1.429, P = 9.111 × 10−10), and neutropenia. Similarly, ER-positive breast cancer (OR = 1.213, P = 5.350 × 10−8), ER-negative breast cancer (OR = 1.179, P = 1.300 × 10−3), and overall breast cancer (OR = 1.275, P = 8.642 × 10−11) also had a causal relationship with agranulocytosis. MVMR analysis showed that ER-positive breast cancer remained causally associated with drug-induced neutropenia (OR = 1.233, P = 4.188 × 10−4), neutropenia (OR = 1.283, P = 6.363 × 10−4), and agranulocytosis (OR = 1.142, P = 4.549 × 10−3). Heterogeneity analysis and pleiotropy test showed that our results were reliable.

Conclusion

Our study provides genetic evidence for a causal association between breast cancer and its estrogen receptor subtypes and neutropenia. In clinical practice, in addition to focusing on therapeutic factors, additional attention should be given to breast cancer patients to avoid severe neutropenia.